期刊文献+

女性膀胱过度活动症(OAB)药物干预的临床研究 被引量:5

Clinical study of treating female OAB by drug intervention
下载PDF
导出
摘要 目的探讨联用M受体阻滞剂与α受体阻滞剂相对于单一应用M受体阻滞剂对女性OAB的疗效影响。方法将受试对象随机分为两组,对照组(M受体阻滞剂,单用卫喜康,5mg,Q.d)63例患者,试验组(联合应用M受体阻滞剂与α受体阻滞剂,卫喜康5mg,q.d+哈乐0.2mg,q.d)63例,连续用药4-8周;嘱患者自行记录排尿日记。结果试验组组联合用药组临床症状改善效果比例(45/63)明显高于对照组(29/63)(P<0.01),两组之间因药物引起的副作用并未对患者身心和生活造成实质性差异性影响。结论卫喜康可以明显改善女性OAB症状,α受体阻滞剂可以高选择性作用于膀胱颈,达到松弛膀胱颈平滑肌作用,可在一定程度上改善患者下腹坠胀的症状;联用M受体阻滞剂与α受体阻滞剂相对于单一应用M受体阻滞剂治疗女性OAB可以达到更好的治疗效果。 Objective To study the effect of M receptor blockers and alpha receptor blockers with separate M receptor blockers on female OAB.Methods Subjects were divided into two groups at random.The control group(M receptor blocker,vesicar,5 mg,Q.d)were 63 patients.The Experimental group(M receptor blockers and alpha receptor blockers,vesicar,5mg,Q.d+Harold,0.2 mg,Q.d)were also 63 patients,drugs were used by 4 to 8 weeks continuously and micturition results were recorded by the patients themselves.Results The effect of experimental group(45/63)was obviously higher than control group(29/63)and the difference was statistically significant(P<0.01).The side effects caused by drugs of the two groups did not have a substantial difference in the physical and mental life of the patients.Conclusion Vesicar can obviously release the symptoms of OAB,alpha receptor blockers can have highly effect on bladder neck and relax the smooth the muscle of bladder,which can improve the symptoms of abdominal distension.The combination of M receptor blockers with alpha receptor blockers in the treatment of female OAB can achieve better effect than M receptor blockers alone.
作者 汤学权 张喜大 余淦 TANG Xuequan;ZHANG Xida;YU Gan(Department of Urinary Surgery,The Second People’s Hospital of Wuxue city,Wuxue 435411,China;Urinary Surgery,Tongji Hospital,Tongji Medical School,Huazhong University of Science and Technology,Wuxue,430030,China.)
出处 《江西医药》 CAS 2018年第3期212-214,共3页 Jiangxi Medical Journal
关键词 女性膀胱过度活动症 卫喜康 Α受体阻滞剂 Female OAB Vesicar Alpha receptor blockers
  • 相关文献

参考文献2

二级参考文献8

  • 1Milsom I,Abrams P,Cardozo L,et al.How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study.BJU Int,2001,87:760.
  • 2Chen GD,Lin TL,Hu SW,et al.Prevalence and correlation of urinary incontinence and overactive bladder in Talwanese women.Neurourol Urodyn,2003,22:109.
  • 3Stewart WF,Van Rooyen JB,Cundiff GW,et al:Prevalence and burden of overactive bladder in the United States.World J Urol,2003,20:327.
  • 4Avery K,Donovan J,Peters TJ,el al.ICIQ:a brief and robust measure for evaluating the symptoms and impact of urinmy incontinence.Neurourol Urodyn,2004,23:322.
  • 5FitzGerald MP,Brubaker L.Urinary incontinence symptom scores and urodynamic diagnoses.Neurourol Urodyn,2002,21:30.
  • 6Abrams,Cardozo,Fall M,et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society[J]. NeurourolUrodyn,2002,21(2) : 167-178.
  • 7Wang Y,Xu K,Hu H, et al. Prevalence risk factors and impact on health related quality of life of overactive bladder in China [J]. Neurourol Urodyn ,2011,30(8) : 1448-1455.
  • 8Rutman MP,Cha DY,Blaivas JG.How do urodynamics findings in- fluence the treatment of the typical patient with overactive bladder [J].Curr Urol Rep, 2012,13(5) : 370-378.

共引文献10

同被引文献35

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部